Diabetes Digital Health, Telehealth, and Artificial Intelligence

"...addresses the technological advances in the field of diabetes care that the healthcare field has used more frequently since the COVID-19 pandemic. [It] shed light on the options, convenience, and efficiency of some current forms of diabetes care including office visits from home and messaging a care team through text messaging.... This book will be of interest to those who care for patients with diabetes and perhaps for patients with diabetes themselves since many have adapted well to the use of an insulin pump, one of the new forms of technology the book discusses. [D]iscusses various topics such as virtual health visits, remote monitoring of diabetic complications, employing artificial intelligence in medication dosing, and much more. Each chapter includes a barriers section and a subsequent solution section.... Anyone interested in diabetes technology whether from a research or pharmaceutical standpoint will find this book useful." --©Doody s Review Service, 2024, Jessica Hwang, MD (Edward Hines, Jr. VA Hospital)

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association's 2019 Outstanding Physician Clinician Award. He has received an FDA Director's Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF.

This began in 2014, with David's appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.

David's recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health.

David's research has also included the use of "food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained "Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes.

You can follow David on 'X' at @godiabetesmd.

Dr. Juan Espinoza is Director of the West Coast Consortium for Technology & Innovation Paediatrics) which is working with a $6.6 million FDA grant. Dr. Espinoza and Klonoff are co-Chairs of iCoDE, the multistakeholder project to create a standard for automatic integration of continuous glucose monitor data into the election health record.